AWAaron R. Winkler

Aaron R. Winkler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aaron R. Winkler has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Amy Imrich

    Harvard School of Public Health, Molecular and Integrative Physiological Sciences Program, 655 Huntington Ave, Building II, 2nd Floor, Boston, MA 02115, USA

    1 shared publication
  • Cara M. M. Williams

    Inflammation, Wyeth Research, Cambridge, Massachusetts, USA

    1 shared publication
  • Glen M. DeLoid

    Nanoscience and Advanced Materials Center, Environmental and Occupational Health Sciences Institute (EOHSI), Rutgers Biomedical Health Sciences, Rutgers University, Piscataway, NJ 08854, USA

    1 shared publication
  • Karl H. Nocka

    Inflammation, Wyeth Research, Cambridge, Massachusetts, USA

    1 shared publication
  • Lester Kobzik

    Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Massachusetts, USA

    1 shared publication
  • Lester Kobzik

    Cellecta, Inc

    1 shared publication

Latest Publications

  • Open Access

    Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry

    by Timothy H Sulahian, Amy Imrich, Glen DeLoid, Aaron R Winkler, Lester Kobzik

    Scavenger receptors are important components of the innate immune system in the lung, allowing alveolar macrophages to bind and phagocytose numerous unopsonized targets. Mice with genetic deletions of scavenger receptors, such as SR-A and MARCO, are susceptible to infection or inflammation from inhaled pathogens or dusts. However, the signaling pathways required for scavenger receptor-mediated phagocytosis of unopsonized particles have not been characterized.


  • IN VITRO MODELING OF HUMAN ALVEOLAR MACROPHAGE SMOKE EXPOSURE: ENHANCED INFLAMMATION AND IMPAIRED FUNCTION

    by Aaron R. Winkler, Karl H. Nocka, Timothy H. Sulahian, Lester Kobzik, Cara M. M. Williams

    Pulmonary macrophages (MØs) are essential for clearance of inhaled particles, innate immunity, and lung tissue maintenance. However, the products of activated MØs have also been implicated in inflammation and tissue destruction, including in chronic obstructive pulmonary disease (COPD). Primary human alveolar macrophages (AMs) are available in limited numbers via bronchoalveolar lavage (BAL) or sputum induction, and BAL macrophages are not commonly available to all researchers. A readily available, plentiful, but representative surrogate for AMs would advance understanding of the contribution of macrophages to lung pathophysiology. Herein the authors describe a method for the in vitro derivation of AM-like cells using primary human peripheral blood monocytes differentiated in suspension with granulocyte-macrophage colony-stimulating factor (GM-CSF). The method produces a cell population with a consistent and stable phenotype. Flow cytometry reveals that GM-CSF–derived macrophages (GM-MØs) express lineage markers, immunoglobulin gamma (Fcγ) receptors, adhesion molecules, antigen presentation coreceptors, and scavenger receptors akin to AMs. Functionally, cigarette smoke activates extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinase, enhances interleukin 8 (IL8) production from GM-MØs and inhibits phagocytosis, phenotypes previously described for smokers' AMs. Global transcriptional profiling revealed significant overlap in regulated genes between smokers' AMs and GM-MØs treated with cigarette smoke preparations in vitro.